GSK launches 3-year cost-savings program to simplify organization, fund R&D push

Reuters2026/07/28 11:06

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

GSK launched a 3-year cost-savings program to simplify the organization, freeing resources to accelerate R&D investment.
Savings will be mainly reinvested in late-stage pipeline priorities, with some used to support margins through the 2028-2030 dolutegravir patent expiry.
Plans include accelerating 7 key late-stage assets across 18 indications, targeting 20+ phase III trial starts in 2026.
GSK will establish a new flagship R&D center on the UK’s Cambridge Biomedical Campus to deepen integration with the local life-sciences ecosystem.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GSK plc published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

GSK launches 3-year cost-savings program to simplify organization, fund R&D push

You may also like

Crypto prices